e-learning resources

Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

New developments in inhaled corticosteroid therapy

Oral Presentation
Chairs: R. Dahl (Aarhus, Denmark), R. Pauwels (Ghent, Belgium)

Download all media

Download all media

Changes in airway inflammation, remodelling and PD20 following inhaled corticosteroid treatment are not temporally concordant C. Ward, R. Bish, M. Pais, D. Reid, E. H. Walters (Tyne and Wear, United Kingdom; Melbourne, Tasmania, Australia)
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) D. Ediger, E. K. Uzaslan, E. G. Yuksel, F. Coskun, N. Ozyardimci, E. Ege (Bursa, Turkey)
Nasal fibroblast functions involved in airway inflammation and remodelling are downregulated by fluticasone propionate (FP) M. Silvestri, F. Sabatini, R. Sale, G. Dasic, G. A. Rossi (Genoa, Verona, Italy)
Preclinical anti-inflammatory activity and safety profile of the novel glucocorticoid ciclesonide D. S. Bundschuh, D. Marx, A. Hatzelmann, R. Beume, D. Haefner, G. Hochhaus, F. Montoro, R. Riedel, M. Stoeck (Konstanz, Germany; Gainesville, United States Of America; Madrid, Spain)
Pharmacokinetic factors affecting airway selectivity of inhaled steroids - role of intracellular esterification S. Edsbacker, C. J. Johansson (Lund, Sweden)
Efficacy and systemic effects of ciclesonide and fluticasone in asthma patients E. Derom, V. Van De Velde, S. Marissens, W. Vincken, R. A. Pauwels (Ghent, Brussels, Belgium)
Pharmacokinetic (PK) and pharmacodynamic (PD) data for inhaled and intranasal corticosteroids (CS) reassessed using a physiological PK/PD model P. T. Daley-Yates, L. N. Pierre (Greenford, United Kingdom)
Mometasone furoate is safe and effective for long-term use in patients with mild-to-moderate persistent asthma A. S. Nayak, K. L. Lampl, N. Segall, J. E. Harrison, C96-136 Study Group (Normal, Rockville, Atlanta, Kenilworth, United States Of America)

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.